Skip to content

Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals

Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals. A Randomized Controlled Trial With Blinded Response Evaluations

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01773343
Enrollment
12
Registered
2013-01-23
Start date
2011-11-30
Completion date
2013-01-31
Last updated
2013-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic Acne Scars

Keywords

skin texture, efficacy, adverse effects

Brief summary

To compare efficacy and adverse effects of fractional CO2 laser of acne scars treatment with 1 versus 3 months intervals

Detailed description

Change in scar texture evaluated by blinded evalutaions. Appearance of erythema, oedema, pigmentation, infection after treatment

Interventions

PROCEDURELaser

Fractionel CO2 laser: 1 versus 3 months intervals

Sponsors

Aarhus University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Have Fitzpatrick skin type I-III. (•Are male or female. * Are between 18 and 60 years of age. * Mild to severe acne scarring. * Are able to read, understand, and sign the Informed Consent. * Are willing and able to comply with all follow-up requirements -

Exclusion criteria

* Have had active localized or systemic infections within 6 months of enrollment * Have compromised ability for wound healing, such as: malnutrition, oral steroid use, history of collagen vascular disease (e.g. lupus, scleroderma, history of keloid formation (raised and thickened scars), atrophic dermatitis (extreme skin irritation or itchiness) or immunologic abnormalities such as vitiligo (white patches of skin due to loss of pigment) * Have been treated with lasers, chemical procedures, or other cosmetic procedures on the area to be treated within 6 months of enrollment * Pregnancy

Design outcomes

Primary

MeasureTime frame
Change in scar texture24 weeks

Secondary

MeasureTime frame
Appearance of erythema, oedema, pigmentation, infection24 weeks

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026